UBS Group’s Marpai, Inc. Class A Common Stock MRAI Stock Holding History

UBS Group’s Portfolio MRAI Stock Details MRAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,578	Closed	-$23.4K	–	10476
2024 Q1	$23.4K	Buy	9,578 +9,462	+8,157%	+$15.1K	﹤0.01%	6860
2023 Q4	$203	Buy	+116	New	+$135	﹤0.01%	8812
2023 Q3	–	Sell	-3,969	Closed	-$6.79K	–	10369
2023 Q2	$6.79K	Buy	3,969 +3,767	+1,865%	+$10.8K	﹤0.01%	7339
2023 Q1	$808	Buy	+202	New	+$737	﹤0.01%	8897
2022 Q2	–	Sell	-867	Closed	-$6K	–	11365
2022 Q1	$6K	Buy	867 +708	+445%	+$6.46K	﹤0.01%	9039
2021 Q4	$3K	Buy	+159	New	+$2.94K	﹤0.01%	9736

UBS Group's MRAI Position: Q2 2024 in Review

UBS Group sold out of Marpai, Inc. Class A Common Stock (MRAI) in Q2 2024, closing a stake of 9,578 shares — an estimated $23.4K sold.

UBS Group first reported a position in MRAI in Q4 2021 and held it in 6 quarters. The position peaked at $23.4K in Q1 2024. 0 funds tracked by Wall St. Rank hold MRAI as of Q2 2024.

UBS Group reported no remaining Marpai, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
UBS Group sold 9,578 Marpai, Inc. Class A Common Stock shares in Q2 2024, an estimated $23.4K.
UBS Group first reported a position in Marpai, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
UBS Group's Marpai, Inc. Class A Common Stock position peaked at $23.4K in Q1 2024.
0 funds tracked by Wall St. Rank held Marpai, Inc. Class A Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.